TANYA HARTE: Open Payments
NPI 1083270797 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 39 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,158 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $181 |
| Lilly USA, LLC | 3 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Abbott Laboratories | 2 | $40 |
| Ipsen Biopharmaceuticals, Inc | 2 | $34 |
| ACADIA Pharmaceuticals Inc | 2 | $32 |
| CSL Behring | 1 | $31 |
| Lundbeck LLC | 1 | $26 |
| SK Life Science, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
Products named: BOTOX, UBRELVY, INGREZZA, VYALEV, INFINITY, KISUNLA, Dysport, NUPLAZID.
Industry payments across MO — which companies pay providers there.
